Baledi Dhurwasulu

Baledi Dhurwasulu is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrazine derivatives. With a total of 2 patents, his inventions focus on compounds that have potential therapeutic applications.

Latest Patents

Dhurwasulu's latest patents include "Pyrazine derivatives as CB2 receptor agonists." This invention relates to a compound of formula (I), wherein Rto Rare is defined as in the description and in the claims. The compound of formula (I) serves as a CB2 receptor agonist for use in the treatment of various disorders, such as pain, atherosclerosis, and glaucoma. Another patent, titled "Pyrazine derivatives," also involves a compound of formula (I) that can be utilized as a medicament. Specifically, this compound may act as a preferential agonist of Cannabinoid Receptor 2.

Career Highlights

Throughout his career, Baledi Dhurwasulu has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in medicinal chemistry.

Collaborations

Dhurwasulu has collaborated with esteemed colleagues such as Uwe Grether and Stephan Roever. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Baledi Dhurwasulu stands out as an influential inventor in the realm of medicinal chemistry. His work on pyrazine derivatives showcases his commitment to developing innovative solutions for various health disorders. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.